(Q36891939)

16 August 2017

1 reference

title

Oxidative stress, AGE, and atherosclerosis (English)

1 reference

16 August 2017

1 reference

Schleicher E

1

1 reference

16 August 2017

Friess U

series ordinal

2

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Kidney International. Supplement

16 August 2017

published in

1 reference

16 August 2017

issue

106

1 reference

16 August 2017

page(s)

S17-26

1 reference

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Role of oxidative modifications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Oxidative stress: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Poor Glycaemic Control is Associated with Reduced Serum Free Radical Scavenging (Antioxidant) Activity in Non-Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Extra- and intracellular localization of advanced glycation end-products in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Saturated, unsaturated, and trans-fatty acids modulate oxidative burst induced by high dextrose in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Metabolic syndrome: a clinical and molecular perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Cell signaling. H2O2, a necessary evil for cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

In-vitro carboxymethylation of low density lipoprotein alters its metabolism via the high-affinity receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Oxidative stress as a regulator of gene expression in the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Kinetic analysis of glycation as a tool for assessing the half-life of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

epsilon-Amino-lysine-bound glucose in human tissues obtained at autopsy. Increase in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Limited nonenzymatic glucosylation of low-density lipoprotein does not alter its catabolism in tissue culture.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Role of lipids in chemical modification of proteins and development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Formation of methylglyoxal and D-lactate in human red blood cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Role of the Maillard reaction in diabetes mellitus and diseases of aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Diabetes and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Understanding RAGE, the receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Atherosclerosis and diabetes: the RAGE connection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Central role of RAGE-dependent neointimal expansion in arterial restenosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

RAGE axis: Animal models and novel insights into the vascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Diabetes and advanced glycoxidation end products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Vascular effects following homozygous disruption of p47(phox) : An essential component of NADPH oxidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Increased atherosclerosis in myeloperoxidase-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Antioxidants and atherosclerosis: don't throw out the baby with the bath water

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002382

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002382

1 reference

Dimensions Publication ID

16 August 2017

1032984716

0 references

1 reference